← Back to Search

Procedure

ExAblate BBBD for Breast Cancer (BBBD Trial)

N/A
Waitlist Available
Led By Nir Lipsman, MD
Research Sponsored by InSightec
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up throughout the study, approximately 10 months.
Awards & highlights

BBBD Trial Summary

This study is evaluating whether a procedure to disrupt the blood brain barrier can be safely used to treat brain metastases in patients with breast cancer.

Eligible Conditions
  • Breast Cancer
  • Brain Tumor

BBBD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~throughout the study, approximately 10 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and throughout the study, approximately 10 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adverse events
Secondary outcome measures
Feasibility of BBBD

BBBD Trial Design

1Treatment groups
Experimental Treatment
Group I: ExAblate BBBDExperimental Treatment1 Intervention
Using ExAblate Model 4000 Type-2 to temporarily disrupt the blood brain barrier in patients with Her-2 positive breast cancer and brain metastases

Find a Location

Who is running the clinical trial?

InSightecLead Sponsor
89 Previous Clinical Trials
3,704 Total Patients Enrolled
3 Trials studying Breast Cancer
114 Patients Enrolled for Breast Cancer
Nir Lipsman, MDPrincipal InvestigatorSunnybrook Health Sciences Centre
2 Previous Clinical Trials
64 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Blood Brain Barrier Disruption (BBBD) Using MRgFUS in the Treatment of Her2-positive Breast Cancer Brain Metastases
2019. "Blood Brain Barrier Disruption (BBBD) Using MRgFUS in the Treatment of Her2-positive Breast Cancer Brain Metastases". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03714243.
All > Brain Metastases
~2 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top